Owens & Minor, Inc. completed its transformation into Accendra Health, Inc. after selling its Products & Healthcare Services segment and the Owens & Minor brand. The remaining public company is focused on home-based care and operates through the Apria and Byram Healthcare brands.
Recurring news for the company centers on financial results, corporate name and ticker changes, material agreements, and home-based care provider relationships. Updates also cover product categories used in chronic and acute care at home, including diabetes, sleep health, respiratory care, wound care, urology and ostomy care.
Owens & Minor, Inc. (NYSE: OMI) reported financial results for Q1 2024 with consolidated revenue of $2.6 billion, a 4% YoY growth. GAAP EPS loss of $(0.29) and adjusted EPS of $0.19. Investments for long-term growth are on track. The company delivered top-line growth, improved profitability, and made strategic investments. The outlook for 2024 includes revenue of $10.5B to $10.9B, adjusted EBITDA of $550M to $590M, and adjusted EPS of $1.40 to $1.70.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.